Metformiinihoitoa

Metformiinihoitoa is the Finnish term for treatment with metformin. Metformin is a medication commonly prescribed to manage type 2 diabetes. It belongs to a class of drugs known as biguanides. The primary mechanism of action of metformin is to reduce the amount of glucose produced by the liver and to increase the body's sensitivity to insulin. This helps to lower blood sugar levels, both fasting and after meals.

Metformin is typically taken orally, usually as a tablet, once or twice a day with meals to minimize gastrointestinal side effects. It is often the first-line medication for individuals diagnosed with type 2 diabetes, especially if they are overweight or obese. Besides its glucose-lowering effects, metformin may also contribute to modest weight loss or weight stabilization, which can be beneficial for many patients with type 2 diabetes.

Common side effects of metformin include gastrointestinal issues such as nausea, diarrhea, and abdominal discomfort, which often subside over time. A rare but serious side effect is lactic acidosis, a buildup of lactic acid in the blood, which requires immediate medical attention. Metformin is generally not recommended for individuals with severe kidney or liver problems, or those with certain heart conditions. Regular monitoring of kidney function is often advised for patients on metformin therapy. It is crucial for patients to take metformin as prescribed by their healthcare provider and to discuss any concerns or side effects.